Thinking creatively about patient involvement in publications
March 7, 2023 | healthcare comms, medical publication professionals, patient involvement in medcomms
Bedrock’s freethinking spirit to reimagine publications is on course to include patients in the full end to end of the publication process.
The International Society for Medical Publication Professionals (ISMPP) 2023 European meeting theme was ‘Fueling Creativity’, and the various topics covered across the 2 days certainly got the Bedrock team thinking. How can we be creative in our approach to delivering compelling and impactful publications and medical communications? One clear area of focus at the meeting was patient involvement in publications, and our team have been reflecting on this and what it means for us as healthcare communication professionals.
Plain language summaries (PLS) have been a hot topic of ISMPP meetings for several years. The value of creating publication content tailored to non-specialist audiences (e.g. time-poor specialists/generalists, payers/policy makers, healthcare professionals [HCPs] with English as a second language, allied HCPs, lay audiences including patients and carers) is now widely recognised by publication professionals; it is becoming increasingly common to see a PLS developed alongside the publication of clinical trial data or as a standalone PLS (plain language summary of a publication). What remains less clear is how patient partners can be effectively engaged and involved throughout the entire end-to-end publication planning and development process.
Good Publication Practice (GPP) 2022 guidance recognises patients as experts who can provide important input into publications at various stages, including during publication planning, as authors and in the development of PLS (see figure below):1
ICMJE, International Committee of Medical Journal Editors; PLS, plain language summary; PLSP, plain language summary of a publication.
Patient involvement in end-to-end publication planning and development has the potential to add huge value through improving accessibility of clinical trial data to non-specialist audiences. However, it is clear that challenges remain and publication professionals need to adopt a more proactive, creative and agile approach to early engagement with patients in the process. Discussion during the ISMPP 2023 meeting brought up some interesting and thought-provoking topics and questions for us to consider moving forwards:
- Identifying the right patient partners is a challenge – how and where can we find patients?
- Appropriate compensation for patients’ time in supporting publication activities is permitted, though remains somewhat controversial – how should/can we navigate this?
- There are many practical things to consider when involving patients in publications to ensure optimal contribution – how can we best make adjustments to processes and timelines to accommodate this?
- Best-practice sharing will support the industry to progress in effective patient involvement in publications – how can we better collaborate and share key learning and information?
- Tools and resources exist to help advocate and coordinate patient involvement in publications and to support development of PLS – how can we raise awareness and better standardise the quality of content?
Overall, great progress has been made over recent years towards involving patients in publications and much of this has focused on PLS development, which has enabled better engagement of non-specialists in healthcare. How can we, as publication and medical communications professionals, contribute to improving patient involvement in the full end-to-end publication process?
As part of our commitment to ‘reimagining publications’, Bedrock is looking at how we can address the key challenges outlined above alongside our patient focused sister agency, Origins. Bedrock and Origins are collaborating to think creatively and compliantly about engagement of patients in the entire publication process. To talk to us about our work in publications and medical communications, and how we improve patient involvement and focus throughout the entire clinical development and lifecycle management process, please contact Louise Adamson louiseadamson@bedrock-health.com
Reference:
- DeTora LM, et al. Ann Intern Med. 2022;175(9):1298–304.
Company Details
Latest Content from Bedrock Healthcare Communications
Why we need to look at rare diseases in a different way
28 February 2021, Rare Disease Day aims to raise awareness of rare diseases and the impact they have on patients’ lives.
The Unknown Unknowns
Patient insights are fundamental to ensuring we understand the reality of living with a condition. We need to consciously challenge our approach and ensure we are unearthing authentic patient insights that...
Do you know what PoTS is?
As part of Dysautonomia Awareness Month, Origins continues its efforts in raising awareness and understanding of Postural Tachycardia Syndrome (PoTS), a Dysautonomia condition affecting young women that can be very...
Leadership change within Bedrock Group
Marie Little appointed Managing Director of Bedrock Healthcare Communications Limited
Origins Insights: views from the team
First in a video series from the Origins Insights team discussing some of our views, experiences, values and opinions across many aspects of qualitative patient research activities.
Bedrock Group strengthens its senior team
Bedrock Healthcare Communications have strengthened its senior management team
PoTS LIVE: A unique ethnography study in rare disease
Digital ethnography has been deployed with PoTS patients for the first time, by Origins Insights, with significant results for the PoTS UK charity.
Intelligence that redefines success
It's true, you can't judge a book by its cover. Digital ethnography uncovers deep, impactful patient insights that can transform thinking and redefine your success.
Origins Insights: Intelligence that redefines success
Origins Insights delivers deep insight and intelligence that can transform thinking and redefine your success.
Bedrock double up
Bedrock selected as a finalist in two categories for 2020 Communiqué awards